Doctor Anywhere (DA), a regional tech-led HealthTech headquartered in Singapore, announced today that it has raised its Series C financing round, led by growth equity investor Asia Partners. The $65.7 million (S$88 million) round included other investors including Novo Holdings, Philips, and OSK-SBI Venture Partners.

Existing investors also participated in the round, including Singapore-based global investor EDBI, Square  Peg, IHH Healthcare, Kamet Capital, and Pavilion Capital.

This round brings the total capital raised by Doctor Anywhere since founding to at least $104.16 million (S$140 million). Oliver Rippel, Co-Founder and Partner of Asia Partners, and Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia will come onboard DA’s Board of Directors.

Doctor Anywhere is a regional tech-enabled, omnichannel healthcare company, which aims to simplify healthcare ensuring access and efficiency. Doctor Anywhere’s digital platform bridges gaps in the healthcare ecosystem through technology and innovation, enabling users to manage their health easily and effectively through the DA mobile app.

Headquartered in Singapore and with a presence in six countries across the region, Doctor Anywhere now serves more than 1.5 million (and growing) users across Southeast Asia. Doctor Anywhere is currently available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines. The group also recently announced the establishment of regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.

Over the past 18 months, the COVID-19 pandemic has also served as a catalyst to fast-track the adoption of telehealth services in the region, an innovation that enabled the healthcare industry to continue providing high-quality, affordable care to families through the crisis.

Lim Wai Mun, founder and CEO of Doctor Anywhere, said: “DA’s mission is to be the largest tech-enabled omnichannel healthcare provider in Southeast Asia, and applying innovative technology to improving patient outcomes is core to our differentiated offerings. We are thrilled to attract the interest of a strong group of investors in this round, a significant milestone which is a testament to our vision and track record.”

DA has built a strong ecosystem of payers, providers, and patients across its core markets. It has close to 2,800 doctors and medical professionals within its network in the region, and it also works closely with major hospitals and healthcare institutions.

This latest investment will significantly bolster DA’s market leadership and put the group in a leading position to further deepen its presence in its existing markets. It will also allow the group to expand into new markets, to drive its mission of transforming the regional healthcare landscape through technology.

“We will utilize this funding to further enhance our digital capabilities, and scale up on our ability to deliver quality healthcare seamlessly to our users in Southeast Asia,” added Lim.

The telemedicine market in the Asia Pacific is expected to register a CAGR of 16.8 percent from 2021 to 2026, according to Research And Markets. This will be driven by factors such as “a rise in healthcare costs, increasing remote patient monitoring, technological innovations, and a growing burden of chronic diseases in the Asia-Pacific region are augmenting the growth of the market.”

Video doctor consultations startup gets $27m funding amid coronavirus outbreak